p21WAF1/CIP1Expression is Differentially Regulated by Metformin and Rapamycin
Authors:
Open Access
- 25 March 2014
- journal article
- research article
- Published by Hindawi Limited in International Journal of Chronic Diseases
- Vol. 2014, 1-17
Abstract
The mammalian target of rapamycin (mTOR) pathway plays an important role in the development of diabetic nephropathy and other age-related diseases. One of the features of DN is the elevated expression of p21WAF1/CIP1. However, the importance of the mTOR signalling pathway in p21 regulation is poorly understood. Here we investigated the effect of metformin and rapamycin on mTOR-related phenotypes in cell lines of epithelial origin. This study reports that metformin inhibits high glucose-induced p21 expression. High glucose opposed metformin in regulating cell size, proliferation, and protein synthesis. These effects were associated with reduced AMPK activation, affecting downstream mTOR signalling. However, the inhibition of the mTOR pathway by rapamycin did not have a negative effect on p21 expression, suggesting that metformin regulates p21 upstream of mTOR. These findings provide support for the hypothesis that AMPK activation may regulate p21 expression, which may have implications for diabetic nephropathy and other age-related pathologies.Keywords
This publication has 121 references indexed in Scilit:
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Transition of kidney tubule cells to a senescent phenotype in early experimental diabetesAmerican Journal of Physiology-Cell Physiology, 2010
- Role of the energy sensor AMP-activated protein kinase in renal physiology and diseaseAmerican Journal of Physiology-Renal Physiology, 2010
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent MannerCell Metabolism, 2010
- PCNA-coupled p21 degradation after DNA damage: The exception that confirms the rule?DNA Repair, 2010
- Essential Role of TGF-β Signaling in Glucose-Induced Cell HypertrophyDevelopmental Cell, 2009
- Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles ofob/obmiceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expressionAmerican Journal of Physiology-Cell Physiology, 2008
- 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor MicroenvironmentsMolecular and Cellular Biology, 2006
- AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancerThe Journal of Physiology, 2006